CAMBRIDGE, England & FOSTER CITY, Calif.--(BUSINESS WIRE)--Researchers from the United Kingdom and the United States are working together to investigate one of science’s most challenging mysteries – the genetic underpinnings of cancer in the human genome. The Wellcome Trust Sanger Institute, a leading genome research institute, and Applied Biosystems (NYSE:ABI), an Applera Corporation business, are sequencing a cancer genome and normal DNA from the same individual to comprehensively detect and characterize the genetic changes that occur during the development of the disease. The purpose of this research is to provide the highest resolution picture to date of genetic variation in the development of cancer. Preliminary scientific findings resulting from this collaboration will be presented at the Cold Spring Harbor Laboratory’s Biology of Genomes meeting in New York from May 6 – 10.
